, 2011; Fuster, - Weill Cornell Brain and Spine
Transcript of , 2011; Fuster, - Weill Cornell Brain and Spine
![Page 1: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/1.jpg)
![Page 2: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/2.jpg)
•
![Page 3: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/3.jpg)
Rogers, Circulation, 2011; Fuster, Circulation, 2006
•
–
–
–
–
•
![Page 4: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/4.jpg)
Fuster, Circulation, 2006
•
•
–
–
![Page 5: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/5.jpg)
Fuster, Circulation, 2006
•
![Page 6: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/6.jpg)
Fuster, Circulation, 2006
•
–
–
–
•
•
![Page 7: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/7.jpg)
Lip, Chest, 2010
•
–
–
–
–
–
–
–
![Page 8: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/8.jpg)
Friberg, Circulation, 2012
0
2
4
6
8
10
12
14
1 2 3 4 5 6 7 8 9 10
An
nu
al R
isk
of
Stro
ke
CHA2DS2VASc Score
![Page 9: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/9.jpg)
Lip, Chest, 2010
![Page 10: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/10.jpg)
Pisters, Chest, 2010
•
–
–
–
–
–
–
–
![Page 11: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/11.jpg)
Pisters, Chest, 2010
0
2
4
6
8
10
12
14
1 2 3 4 5 6
An
nu
al R
isk
of
Ble
ed
ing
HASBLED Score
![Page 12: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/12.jpg)
Figure.
The net clinical benefit of warfarin by age group (top) and CHADS2 score (bottom). Net clinical
benefit is plotted as the adjusted, weighted adverse events prevented per 100 person-years by
warfarin treatment, according to age group and CHADS 2 score, respectively. Intracranial
hemorrhage is weighted as 1.5 times the value of thromboembolism (see Methods section).
Stratified rates for CHADS2 score are not further adjusted. CHADS2 = Congestive Heart
Failure/Hypertension/Age/Diabetes/Prior Stroke2.
Singer et al. Page 12
Ann Intern Med. Author manuscript; available in PMC 2010 March 1.
NIH
-PA
Au
tho
r Ma
nuscrip
tN
IH-P
A A
uth
or M
anu
scrip
tN
IH-P
A A
uth
or M
an
uscrip
t
Fang, Ann Intern Med, 2009
•
•
•
![Page 13: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/13.jpg)
•
–
–
–
•
–
•
–
![Page 14: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/14.jpg)
Dabigatran Rivaroxaban Apixaban
Average age 72 73 70
Average CHADS2 2.1 3.5 2.1
Prior stroke/TIA 20% 55% 20%
Connolly, NEJM, 2009; Granger, NEJM, 2011; Patel, NEJM, 2011
![Page 15: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/15.jpg)
Connolly, NEJM, 2009; Granger, NEJM, 2011; Patel, NEJM, 2011
Dabigatran Rivaroxaban Apixaban
Blinding Single Double Double
Sample size 18,113 14,264 18,201
Follow-up 2.0 yrs 1.9 yrs 1.8 yrs
Mean TTR 64% 55% 62%
Discontinued 21 v. 17% 24 v. 22% 25 v. 28%
![Page 16: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/16.jpg)
Connolly, NEJM, 2009; Granger, NEJM, 2011; Patel, NEJM, 2011
Dabigatran Rivaroxaban Apixaban
Stroke: 0.66 0.79 0.79
ICH: 0.40 0.67 0.42
MI: 1.38 0.81 0.88
Death: 0.88 0.92 0.89
![Page 17: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/17.jpg)
Connolly, NEJM, 2009; Granger, NEJM, 2011; Patel, NEJM, 2011
Dabigatran Rivaroxaban Apixaban
Stroke:
Active 1.11% 1.7% 1.27%
Warfarin 1.69% 2.2% 1.60%
ICH:
Active 0.30% 0.5% 0.33%
Warfarin 0.74% 0.7% 0.80%
![Page 18: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/18.jpg)
Hart, Stroke, 2012; FDA, fda.gov, 2012
•
•
![Page 19: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/19.jpg)
Freeman, Ann Intern Med, 2011; Shah, Circulation, 2011; Kamel, Stroke, 2011; Lee, Am J Cardiol, 2012; Lee, PLoS One, 2012; Kamel, Neurology, 2012
•
–
–
–
![Page 20: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/20.jpg)
•
•
![Page 21: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/21.jpg)
You, Chest, 2012; Cairns, Can J Cardiol, 2012
•
•
•
![Page 22: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/22.jpg)
Donze, Am J Med, 2012; Healey, NEJM, 2012; You, Chest, 2012;
•
•
•
•
![Page 23: , 2011; Fuster, - Weill Cornell Brain and Spine](https://reader036.fdocuments.in/reader036/viewer/2022081503/62a1c6baa1c3596ea727ad50/html5/thumbnails/23.jpg)
•
•
•
•